Steris Stock News
$266.85
0.35%
day before yesterday
NYSE,
Nov 26, 10:38 pm CET
Index
Industry
Steris Stock News
Neutral
Seeking Alpha
●
21 days ago
STERIS plc ( STE ) Q2 2026 Earnings Call November 6, 2025 9:00 AM EST Company Participants Julie Winter - Vice President of Investor Relations & Corporate Communications Karen Burton - Senior VP, CFO & Chief Accounting Officer Daniel Carestio - President, CEO & Director Conference Call Participants Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Patrick Wood - Morgan Stanley, Re...
Neutral
GlobeNewsWire
●
22 days ago
Total revenue from continuing operations increased 10%; constant currency organic revenue grew 9% As reported EPS from continuing operations increased to $1.94; adjusted EPS increased to $2.47 Fiscal 2026 constant currency organic revenue, EPS and free cash flow outlook increased DUBLIN, IRELAND , Nov. 05, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announc...
Neutral
GlobeNewsWire
●
29 days ago
DUBLIN, IRELAND, Oct. 29, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on December 18, 2025, to shareholders of record at the close of business on November 18, 2025.
Neutral
GlobeNewsWire
●
about one month ago
DUBLIN, IRELAND, Oct. 21, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 second quarter results at 9:00 a.m. ET on November 6, 2025. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-800-715-9871 in the United States or 1-646-307-1963 internationally, th...
Positive
Seeking Alpha
●
3 months ago
STERIS remains a high-quality, defensive cash recycler with diversified growth, expanding margins, strong cash conversion, and disciplined capital deployment. Q1 FY'26 results showed broad-based 9% revenue growth, margin expansion across all segments, and raised full-year guidance, supporting my positive investment view. Valuation is fair with upside to $270–$300/share; the company excels at re...
Neutral
Seeking Alpha
●
4 months ago
STERIS plc (NYSE:STE ) Q1 2026 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Daniel A. Carestio - President, CEO & Director Julie Winter - Vice President of Investor Relations & Corporate Communications Michael J.
Neutral
The Motley Fool
●
4 months ago
Steris (STE) Q1 Revenue Rises 8%
Neutral
GlobeNewsWire
●
4 months ago
Long-time CFO Michael J. Tokich to be succeeded by Karen L.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
